Oneness Ranked among Top 5% in the 8th Corporate Governance Evaluation
![]() |
The results for the 8th Corporate Governance Evaluation has been announced on April 28, 2022. Oneness ranks among top 5% in the TPEx-listed category and the top 10% of listed companies with a market capital of 10 billion TWD or more in the non-finance and non-electronics industry, recognizing Oneness’s excellent performance and efforts in corporate governance and sustainability.
|
2021 ESG Performance
- The Nanchou Plant obtained ISO 14001:2015 Environment Management System certification. The disposal process and management of waste gas, waste water, wastes and toxic substances, and pollution prevention all in compliance with regulatory requirements.
- The Nanchou Plant has received the outstanding performance award of 2020 and 2021 Pingtung County Green Procurement for Private Businesses and Organizations for 2 years in a row.
- The product carbon footprint inventory project has been initiated at the Nanchou Plant since 2021 Q3 and third-party certified in April 2022.
- TCFD (Task Force on Climate-Related Financial Disclosures) has been introduced in 2021 to identify the influence of climate change on operations and mitigation and adaptation strategies.
- Oneness has been included in the 2021-2022 Bloomberg Gender-Equality Index and was the only Taiwan biotech company to receive this honor.
- The Nanchou Plant has been certified according to ISO 45001:2018 - Occupational Health and Safety Management Systems, to build a healthy and safe workplace.
- “The Supplier Management Procedure” has been amended to require suppliers to sign a Supplier CSR Commitment Letter. The employees’ welfare and rights, environmental protection, occupational safety and health, ethical principle and anti-corruption of the supply chain are included in the assessment and inspection of suppliers. 32 suppliers signed the Letter in 2021. We worked with them to build a “sustainable supply chain” to create positive social impact.
- In the 8th TWSE Corporate Governance Evaluation , Oneness has been ranked among the top 5% in the TPEx-listed category and the top 10% among listed companies with a market capital of 10 billion TWD or more in the non-finance and non-electronics industry, acknowledging Oneness’s excellent performance and efforts in corporate governance and sustainability
- Oneness was the only Taiwan biotech company invited to participant in 2021 Dow Jones Sustainability Indices (DJSI) assessment in DRG Pharmaceuticals industry.
- Oneness ranks BBB (Average) in MSCI ESG rating with superior performance in “product safety” and “corporate governance.”
- Oneness is certified in accordance with ISO 9001:2015 - Quality Management System, to improve product quality and safety comprehensively.
- Oneness was also awarded Taiwan Intellectual Property Management System (TIPS) certification from the Institute of Taiwan Industry to safeguard the intellectual property management system.
Awards
2022
|
2022
|
2019
|
2016
|
Ranked among Top 5% in the 8th Corporate Governance Evaluation | 2022 Bloomberg Gender - Equality Index (GEI) |
2019 Taipei Biotech Awards, Innovation Bronze Medal Award (Note) | 2016 13th National Innovation Award, Corporate Innovation Award, Bio-pharmaceutical and New Medical Technology Group (Note) |
2016
|
2016
|
2014
|
2013
|
2016 Drug Research and Development Science and Technology Award Co-Hosted by MOHW and MOEA - Bronze Medal Award (Note) |
2016 Drug Research and Development Science and Technology Award Co-Hosted by MOHW and MOEA - Bronze Medal Award |
2014 National Biotechnology and Medical Care Quality Award - Bronze Medal Award for Health Food Group, Nutrient Health Food Category | 2013 Taipei Biotech Awards - Silver Medal Award for Technology Transfer |
2010
|
|||
Certificate of 2010 Symbol of National Quality |
Note: Oneness Biotech merged with Fountain BioPharma in 2019 and inherited its rights and obligations.
In 2021, Oneness Biotech was invited to take part in the S&P Corporate Sustainability Assessment and was rated |
Oneness Biotech improves its transparency and ESG actions persistently, is rated as in the top 16th percentile of biotech and |
※The above content is taken from the ESG Report